Edition:
United States

Profile: SeaSpine Holdings Corp (SPNE.O)

SPNE.O on Nasdaq

14.07USD
2:24pm EDT
Change (% chg)

$-0.18 (-1.26%)
Prev Close
$14.25
Open
$14.16
Day's High
$14.48
Day's Low
$13.72
Volume
43,865
Avg. Vol
85,403
52-wk High
$20.75
52-wk Low
$11.16

SeaSpine Holdings Corporation, incorporated on February 12, 2015, is a medical technology company. The Company is focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. The Company operates through the development, manufacture and marketing of orthobiologics and spinal fusion hardware segment. The Company has a portfolio of orthobiologics and spinal fusion hardware solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures in the lumbar, thoracic and cervical spine.

The Company offers a portfolio of orthobiologics and spinal fusion hardware products for the treatment of patients suffering from spinal and other orthopedic disorders. The Company's orthobiologics products consist of a range of bone graft substitutes that are designed to improve bone fusion rates following a range of orthopedic surgeries, including spine, hip and extremities procedures. Its orthobiologics portfolio is used in orthopedic and dental procedures. Its products include demineralized bone matrices, collagen ceramic matrices, demineralized cancellous allograft bone and synthetic bone void fillers. The Company offers these products in the form of putties, pastes and strips for a range of surgical applications. Its Accell technology combines its dispersed Accell Bone Matrix with a particulate-based demineralized bone matrix. Its other bone graft substitutes products consist of allograft cancellous bone scaffolds and synthetic bone void fillers.

The Company's spinal fusion hardware portfolio consists of a line of products to facilitate spinal fusion in minimally invasive surgery (MIS), complex spine, deformity and degenerative procedures. The Company sells orthobiologics and spinal fusion hardware products across North America, Europe, Asia Pacific and Latin America. Its MIS products enable a surgeon to perform a procedure less invasively than open surgery, which results in reduced postoperative pain, faster rates of healing and fewer procedure complications by minimizing incision size and tissue dissection. The Company's surgeon customers utilize its iPassage MIS Retractors and NewPort Tube Retractors to perform MIS fusions and decompression procedures, a surgical technique used to alleviate pain caused from compression on the spinal cord or the nerves that emanate from it. Its spinal fusion hardware products are used in complex spine and deformity procedures involving multiple spine segments, challenging anatomy, tumors, traumatic injury and revision of previous fusion surgeries. The Company's complex fusion hardware portfolio allows surgeons to combine various product lines and approaches, offering several treatment options for the difficult cases.

The Company's deformity platform consists of several technologies to address the needs of its deformity surgeons and the various derotation techniques that they use to correct the curvature of the spine. The Company's degenerative products include systems that are used in open procedures. It offers a portfolio of degenerative products that are designed for use in both thoracolumbar and cervical spine cases. It offers a portfolio of products for the thoracic and lumbar regions of the spine, consisting of rods, screws and instrumentation for posterior lumbar fusion and a broad range of anterior, posterior and lateral interbody devices (IBDs), including PEEK-OPTIMA and NanoMetalene-coated devices. Its Malibu and Coral screw and plating systems are its core products used for treating degenerative thoracolumbar spine cases. It offers a range of devices to treat disorders in the cervical region of the spine. Its degenerative cervical portfolio includes a range of interbody devices, including zero-profile systems, integrated plate interbody devices, and PEEK-OPTIMA and NanoMetalene-coated interbody systems. In addition, it offers a range of screw and plating systems.

The Company competes with Alphatec, Bacterin, XTANT Medical, Baxter, Biomet, Johnson & Johnson, Globus Medical, Medtronic, NuVasive, K2M, LDR, Orthofix, RTI Surgical, Stryker and Zimmer.

Company Address

SeaSpine Holdings Corp

5770 Armada Dr
CARLSBAD   CA   92008-4608
P: +1760.7278399
F: +1302.6365454

Company Web Links